Kodiak Sciences Inc

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: Kodiak Sciences Inc
Former names: Oligasis, LLC
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2836 — Biological Products, (No Diagnostic Substances)
Jurisdiction of incorporation: Delaware
Headquarters city: Palo Alto
Headquarters state / province: California
Headquarters country: United States
Fiscal year end: December
Ticker symbol: KOD
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0001468748
EIN: 27-0476525
Wikidata ID: Q106301447

Board of directors

Follow this board

Bassil I. Dahiyat · Director
Since 2023
Charles A. Bancroft · Director
Since 2023
Felix Baker · Director Overboarded
Since 2023
Julian Baker · Director Overboarded
Since 2023
Richard S. Levy · Director
Since 2023
Robert Profusek · Director
Since 2023
Taiyin Yang · Director
Since 2023
Victor Perlroth · Director · Chairman and CEO
Since 2023

Chief executives

Victor Perlroth · Chairman and CEO

Dates unknown

Director election results

Annual meeting of June 2, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

5 of this board's directors also sit on 19 other boards. 17 are in the same sector.

Shared director Other board Same sector +3 more in the list below

Kiniksa Pharmaceuticals International plc Same sector
via Felix Baker, Julian Baker and Richard S. Levy
Madrigal Pharmaceuticals Inc. Same sector
via Felix Baker, Julian Baker and Richard S. Levy
ACADIA Pharmaceuticals Inc. Same sector
via Felix Baker and Julian Baker
BeOne Medicines Ltd. Same sector
via Felix Baker and Julian Baker
Bicycle Therapeutics plc Same sector
via Felix Baker and Julian Baker
DBV Technologies S.A. Same sector
via Felix Baker and Julian Baker
Denali Therapeutics Inc. Same sector
via Felix Baker and Julian Baker
Immunocore Holdings plc Same sector
via Felix Baker and Julian Baker
Incyte Corp. Same sector
via Felix Baker and Julian Baker
Kymera Therapeutics Inc. Same sector
via Felix Baker and Julian Baker
Neurogene Inc. Same sector
via Felix Baker and Julian Baker
Prelude Therapeutics Incorporated Same sector
via Felix Baker and Julian Baker
Replimune Group Inc. Same sector
via Felix Baker and Julian Baker
TScan Therapeutics Inc. Same sector
via Felix Baker and Julian Baker
vTv Therapeutics Inc. Same sector
via Felix Baker and Julian Baker
CTS Corporation
via Robert Profusek
Protara Therapeutics Inc. Same sector
via Richard S. Levy
Valero Energy Corporation
via Robert Profusek
Xencor Inc. Same sector
via Bassil I. Dahiyat

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $241,330,147; 88 purchases by 5 insiders
Sold, last 12 months: $4,920,820; 14 sales by 1 insider

Date	Insider	Transaction	Shares	Price	Value
Nov 5, 2026	BAKER BROS. ADVISORS LP Director, 10% owner	Open-market purchase	+4,703	$98.51	$463,293
Nov 5, 2026	BAKER BROS. ADVISORS LP Director, 10% owner	Open-market purchase	+81,729	$98.51	$8,051,124
Nov 4, 2026	BAKER BROS. ADVISORS LP Director, 10% owner	Open-market purchase	+8,742	$98.51	$861,174
Nov 4, 2026	BAKER BROS. ADVISORS LP Director, 10% owner	Open-market purchase	+151,916	$98.51	$14,965,245
Oct 23, 2026	Taiyin Yang Director	Option exercise	+20,000	$2.35	$47,000
Oct 21, 2026	BORGESON JOHN A. Officer (Chief Financial Officer)	Option exercise	+30,000	$2.49	$74,700
Oct 21, 2026	BORGESON JOHN A. Officer (Chief Financial Officer)	Open-market sale	−8,514	$87.67	$746,422
Oct 21, 2026	BORGESON JOHN A. Officer (Chief Financial Officer)	Open-market sale	−1,677	$89.20	$149,588
Oct 21, 2026	BORGESON JOHN A. Officer (Chief Financial Officer)	Open-market sale	−7,623	$89.74	$684,088
Oct 21, 2026	BORGESON JOHN A. Officer (Chief Financial Officer)	Open-market sale	−5,101	$90.98	$464,089
Oct 21, 2026	BORGESON JOHN A. Officer (Chief Financial Officer)	Open-market sale	−2,985	$91.76	$273,904
Oct 21, 2026	BORGESON JOHN A. Officer (Chief Financial Officer)	Open-market sale	−2,000	$92.66	$185,320
Oct 21, 2026	BORGESON JOHN A. Officer (Chief Financial Officer)	Open-market sale	−2,000	$93.71	$187,420
Oct 21, 2026	BORGESON JOHN A. Officer (Chief Financial Officer)	Open-market sale	−100	$94.91	$9,491
Sep 29, 2026	667, L.P. Director, 10% owner	Open-market purchase	+619	$84.24	$52,145

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about Kodiak Sciences Inc

Who is the CEO of Kodiak Sciences Inc?

Victor Perlroth is Kodiak Sciences Inc's Chairman and CEO.

How many directors are on Kodiak Sciences Inc's board?

Kodiak Sciences Inc's board has 8 directors: Bassil I. Dahiyat, Charles A. Bancroft, Felix Baker, Julian Baker, Richard S. Levy, Robert Profusek, Taiyin Yang and Victor Perlroth.

Are Kodiak Sciences Inc insiders buying or selling shares?

Over the last 12 months, Kodiak Sciences Inc insiders bought $241.3 million of shares in 88 purchases and sold $4.9 million of shares in 14 sales on the open market, as reported to the SEC on Forms 4 and 5.

How is Kodiak Sciences Inc connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="kodiak-sciences-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.